Oruka Therapeutics (ORKA) Operating Expenses (2010 - 2024)

Oruka Therapeutics' Operating Expenses history runs 15 years deep, the most recent figure standing at $3.1 million for Q2 2024.

• In Q2 2024, Operating Expenses rose 58.24% year-over-year to $3.1 million; the TTM figure through Mar 2025 stood at $3.1 million (down 60.89% YoY), while the FY2023 annual figure was $7.3 million, down 31.14% from the prior year.
• Operating Expenses was $3.1 million for Q2 2024 at Oruka Therapeutics, up from $2.5 million in the prior quarter.
• In the past five years, Operating Expenses ranged from a high of $5.7 million in Q4 2021 to a low of $1.3 million in Q2 2020.
• Historically, Operating Expenses has averaged $2.9 million across 5 years, with a median of $2.5 million in 2022.
• The sharpest annual moves came in 2020 and 2022: Operating Expenses soared 301.1% in 2020, then sank 72.75% in 2022.
• A 5-year view of Operating Expenses shows it stood at $5.1 million in 2020, then climbed by 10.81% to $5.7 million in 2021, then tumbled by 72.75% to $1.5 million in 2022, then grew by 2.71% to $1.6 million in 2023, then jumped by 96.35% to $3.1 million in 2024.
• The last three Operating Expenses figures came in at $3.1 million (Q2 2024), $2.5 million (Q1 2024), and $1.6 million (Q4 2023), per Business Quant data.